When Parallel Roads Meet: Orchestrating Collaborations Between Regulatory, Ethical, and Business Partners in Translational Medicine
Front Med (Lausanne)
.
2019 May 3:6:87.
doi: 10.3389/fmed.2019.00087.
eCollection 2019.
Authors
Uri Tabori
1
2
,
Joseph Ferenbok
2
,
Emmanuel Thomas
3
,
Joost Frans Swart Thomas
4
,
Salvatore Albani
5
,
Vicki Seyfert-Margolis
6
,
Emilie Sauvage
7
Affiliations
1
Department of Paediatrics, Hospital for Sick Children, Toronto, ON, Canada.
2
Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.
3
Leonard M. Miller School of Medicine, University of Miami, Miami, FL, United States.
4
Department of Pediatric Rheumatology & Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
5
Translational Immunology and Inflammation Centre, SingHealth, Singapore, Singapore.
6
MyOwnMed, Inc., Bethesda, MD, United States.
7
Institute of Cardiovascular Science, University College London, London, United Kingdom.
PMID:
31131276
PMCID:
PMC6509226
DOI:
10.3389/fmed.2019.00087
No abstract available
Keywords:
business; innovators; patients; regulators; translational medicine.